Portal hemodynamic effects of regorafenib in patients with advanced hepatocellular carcinoma: a prospective cohort study
Not Applicable
- Conditions
- patients with advanced hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000029648
- Lead Sponsor
- Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Tumor invasion in intrahepatic large vessels was classified according to the criteria of the Liver Cancer Study of Japan as portal tumor invasion involving first-order-branches (Vp3) and the main trunk of the portal vein (Vp4), or as tumor invasion involving first-order branches of the hepatic vein (Vv2) and the inferior vena cava (Vv3).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in portal venous area
- Secondary Outcome Measures
Name Time Method